Key facts
- This page summarizes Thomas H. Mclain's Form 3 filing for Renalytix plc (RNLXY).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Jul 2023, 16:22.
Thomas H. Mclain - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)
- Reporting relationship
- President
- Issuer ticker
- RNLXY
- Reported as of
- 01 Jul 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 Jul 2023, 16:22:25 UTC
- Next SEC filing
- 07 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Katie Kazem, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas H. Mclain filed Form 3 for Renalytix plc (RNLXY) on 03 Jul 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RNLX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 59,150
- Date
- 01 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RNLX
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 538,161
- Exercise price
- Footnotes
- F2, F3
RNLX
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 200,000
- Exercise price
- Footnotes
- F4, F5
RNLX
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 500,000
- Exercise price
- Footnotes
- F2, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
Footnote F2
Fully vested and exercisable.
Footnote F3
The exercise price is 2.02 pounds sterling. The U.S. dollar equivalent of the exercise price is $2.55 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).
Footnote F4
One twelfth (1/12th) of the shares subject to the option award vested or shall vest in equal quarterly installments commencing on November 28, 2020, subject to the Reporting Person's continuous service.
Footnote F5
The exercise price is 5.50 pounds sterling. The U.S. dollar equivalent of the exercise price is $6.94 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).
Footnote F6
The exercise price is 9.25 pounds sterling. The U.S. dollar equivalent of the exercise price is $11.67 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney